Medigen Vaccine Biologics Competitors and Similar CompaniesClear all
Medigen Vaccine Biologics's competitors and similar companies include Mycenax Biotech, Alembic Pharmaceuticals, EMS Pharma and Genentech.
 Medigen Vaccine Biologics Medigen Vaccine Biologics (高端疫苗生物製劑股份有限公司) is a company developing vaccines and biosimilars to prevent regional infectious diseases. |  Mycenax Biotech Mycenax Biotech (永昕生物醫藥股份有限公司) is a company that provides biopharmaceutical development services. |  Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates |  EMS Pharma EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals. |  Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. | |
Founding Date | Founding Date 2012 | Founding Date 2001 | Founding Date 2010 | Founding Date 1964 | Founding Date 1976 |
Type | Type Public | Type Public | Type Public | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations TW HQ | Locations Zhunan, TW HQ Taipei, TW Zhunan, TW | Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN | Locations BR HQ | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more |
Employees | Employees 103 | Employees 387 | Employees 14,858 | Employees 12,7441% increase | Employees 18,077 |
Financial | |||||
Revenue (est.) | Revenue (est.) NT$605.6m (FY, 2024) | Revenue (est.) NT$740.2m (FY, 2025) | Revenue (est.) ₹73.4b (FY, 2026) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods NT$72.8m (FY, 2024) | Cost of goods NT$637.3m (FY, 2025) | Cost of goods ₹19.8b (FY, 2026) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit NT$532.9m (FY, 2024) | Gross profit NT$114.2m (FY, 2025) | Gross profit ₹54.1b (FY, 2026) | Gross profit N/A | Gross profit N/A |
Net income | Net income (NT$80.5m) (FY, 2024) | Net income (NT$448.6m) (FY, 2025) | Net income ₹6.7b (FY, 2026) | Net income N/A | Net income N/A |
Operating ⚠ | |||||
Manufacturing Facilities | Manufacturing Facilities N/A | Manufacturing Facilities 2 (Sep, 2023) | Manufacturing Facilities 9 (FY, 2024) | Manufacturing Facilities N/A | Manufacturing Facilities N/A |
For sources of this data, please see the company profile
View Company Profiles
Mycenax Biotech
HQ
Zhunan, TW
Employees
387
Mycenax Biotech (永昕生物醫藥股份有限公司) is a company that provides biopharmaceutical development services.
View companyAlembic Pharmaceuticals
HQ
Vadodara, IN
Employees
14,858
Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates
View companyEMS Pharma
HQ
BR
Employees
12,744↑ 1% increase
EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals.
View companyGenentech
HQ
South San Francisco, US
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
View company